期刊
JACC-CARDIOVASCULAR INTERVENTIONS
卷 4, 期 9, 页码 992-1001出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcin.2011.03.020
关键词
bioresorbable scaffolds; incomplete stent; late acquired incomplete stent; optical coherence tomography; strut apposition; uncovered struts
资金
- Abbott Vascular (Santa Clara, California)
- Abbott
- Cordis
- Medtronic
- Biosensors
- Boston Scientific
- Adamed
- AstraZeneca
- Biotronik
- Balton
- Bayer
- BBraun
- BioMatrix
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Cook
- Eli Lilly
- EuroCor
- Glaxo
- Invatec
- Medicines Co.
- MSD
- Nycomed
- Orbus-Neich
- Pfizer
- Possis
- Promed
- Sanofi-Aventis
- Siemens
- Solvay
- Terumo
- Tyco
- Abbott Vascular
Objectives The aim of this study is to assess the serial changes in strut apposition and coverage of the bioresorbable vascular scaffolds (BVS) and to relate this with the presence of intraluminal masses at 6 months with optical coherence tomography (OCT). Background Incomplete strut/scaffold apposition (ISA) and uncovered struts are related to a higher risk of scaffold thrombosis. Bioresorbable vascular scaffolds can potentially avoid the risk of scaffold thrombosis because of its complete resorption. However, during the resorption period, the risk of scaffold thrombosis is unknown. Methods OCT was performed in 25 patients at baseline and 6 months. Struts were classified according to apposition, coverage, and presence of intraluminal masses. Persistent ISA was defined as malapposed struts present at baseline and follow-up, and late acquired ISA as ISA developing at follow-up, and scaffold pattern irregularities when the strut distribution suggested scaffold fracture. Results At baseline, 3,686 struts were analyzed: 128 (4%) were ISA, and 53 (1%) were located over side-branches (SB). At 6 months, 3,905 struts were analyzed: 32 (1%) ISA, and 35 (1%) at the SB. Persistent ISA was observed more frequently than late acquired-ISA (81% vs. 16%, respectively; 3% were unmatchable). Late acquired ISA was associated with scaffold pattern irregularities, which were related to overstretching of the scaffold. Uncovered struts (63 struts, 2%) were more frequently observed in ISA and SB struts, compared with apposed struts (29% vs. 1%; p < 0.01). Intraluminal masses (14 cross-sections, 3%; in 6 patients, 24%) were more frequently located at the site of ISA and/or uncovered struts (39% vs. 2% and 13% vs. 2%, respectively; p < 0.01). Conclusions The lack of strut apposition at baseline is related to the presence of uncovered struts and intraluminal masses at 6 month. An appropriate balloon/artery ratio respecting the actual vessel size and avoiding the overstretching of the scaffold can potentially decrease the risk of scaffold thrombosis. (ABSORB Clinical Investigation, Cohort B [ABSORB B]; NCT00856856) (J Am Coll Cardiol Intv 2011;4:992-1001) (C) 2011 by the American College of Cardiology Foundation
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据